Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-17

Clinical Trial Update: Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral fecal microbiota transplantation for pediatric ulcerative colitis in remission, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pediatric Ulcerative Colitis in Remission | Phase 2 | Status: NOT_YET_RECRUITING